Summit Therapeutics Inc. Quarterly Depreciation in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Summit Therapeutics Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q1 2024.
  • Summit Therapeutics Inc. Depreciation for the quarter ending March 31, 2024 was $27K, a 70% decline year-over-year.
  • Summit Therapeutics Inc. annual Depreciation for 2023 was $198K, a 43.3% decline from 2022.
  • Summit Therapeutics Inc. annual Depreciation for 2022 was $349K, a 5.76% increase from 2021.
  • Summit Therapeutics Inc. annual Depreciation for 2021 was $330K, a 9.27% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $27K -$63K -70% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q1 2023 $90K +$21K +30.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q1 2022 $69K -$11K -13.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $80K +$8K +11.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q1 2020 $72K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.